BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 2 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2023. The put-call ratio across all filers is - and the average weighting 6.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $46,000 | -63.8% | 306 | -65.0% | 0.00% | – |
Q2 2022 | $127,000 | +81.4% | 874 | +49.1% | 0.00% | – |
Q1 2022 | $70,000 | +2.9% | 586 | +19.1% | 0.00% | – |
Q4 2021 | $68,000 | +580.0% | 492 | +593.0% | 0.00% | – |
Q3 2021 | $10,000 | +900.0% | 71 | +688.9% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 9 | -30.8% | 0.00% | – |
Q1 2021 | $1,000 | -96.0% | 13 | -95.4% | 0.00% | – |
Q4 2020 | $25,000 | +2400.0% | 284 | +2740.0% | 0.00% | – |
Q4 2019 | $1,000 | – | 10 | 0.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 10 | -96.5% | 0.00% | – |
Q2 2019 | $12,000 | +300.0% | 288 | +433.3% | 0.00% | – |
Q1 2019 | $3,000 | – | 54 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |